Evaluation of Versalyse as an alternative red blood cell lysing agent in the evaluation of CD34 stem and progenitor cells with the ISHAGE guidelines.
Lori E LowesBenjamin D HedleyD Robert SutherlandMichael KeeneyPublished in: Cytometry. Part B, Clinical cytometry (2020)
Keyphrases